Annovis Bio, Inc.(ANVS)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | Hoffman Michael B Director | Purchase | +76,344 | +2.32%3,364,883 | $1.87 | $142,779 | View SEC filing | |
| 2026-04-03 | Hoffman Michael B Director | Purchase | +713,800 | +27.72%3,288,539 | $2.10 | $1,498,980 | View SEC filing | |
| 2025-12-08 | Hoffman Michael B Director | Purchase | +45,000 | +1.78%2,574,739 | $4.31 | $193,794 | View SEC filing | |
| 2025-11-25 | Hoffman Michael B Director | Purchase | +39,200 | +1.57%2,529,739 | $4.08 | $159,886 | View SEC filing | |
| 2025-11-25 | Hoffman Michael B Director | Purchase | +39,200 | +1.58%2,519,739 | $4.08 | $159,886 | View SEC filing | |
| 2025-11-21 | Hoffman Michael B Director | Purchase | +20,000 | +0.81%2,490,539 | $3.50 | $69,900 | View SEC filing | |
| 2025-11-18 | Hoffman Michael B Director | Purchase | +15,000 | +0.61%2,470,539 | $2.11 | $31,650 | View SEC filing | |
| 2025-11-12 | Maccecchini Maria-Luisa President & CEO | Purchase | +97,561 | +8.75%1,212,020 | $2.05 | $200,000 | View SEC filing | |
| 2025-11-12 | Hoffman Michael B Director | Purchase | +975,610 | +65.92%2,455,539 | $2.05 | $2,000,001 | View SEC filing | |
| 2021-10-13 | Bruck Claudine Director | Purchase | +181 | +3.08%6,067 | $27.66 | $5,006 | View SEC filing | |
| 2021-10-13 | White Mark K. Director | Purchase | +5,000 | +9.77%56,177 | $27.40 | $137,000 | View SEC filing | |
| 2021-10-13 | Maccecchini Maria-Luisa PRESIDENT AND CEO | Purchase | +18,000 | +1.88%976,775 | $27.61 | $496,980 | View SEC filing | |
| 2021-08-23 | McCarthy Reid Director | Purchase | +500 | +7.90%6,829 | $37.61 | $18,805 | View SEC filing | |
| 2020-02-05 | Hoffman Michael B Director, 10% Owner | Purchase | +33,333 | +233.33%47,619 | $6.00 | $199,998 | View SEC filing | |
| 2020-02-05 | Whelan, Jr. Robert M. Director | Purchase | +25,000 | +100.00%25,000 | $6.00 | $150,000 | View SEC filing | |
| 2020-02-05 | Bruck Claudine Director | Purchase | +800 | +100.00%800 | $6.00 | $4,800 | View SEC filing | |
| 2020-02-05 | Maccecchini Maria-Luisa President and CEO | Purchase | +1,600 | +0.78%207,942 | $6.00 | $9,600 | View SEC filing | |
| 2020-02-05 | McGroarty Jeffrey Brian Chief Financial Officer | Purchase | +52,833 | +100.00%52,833 | $6.42 | $339,426 | View SEC filing | |
| 2020-02-05 | White Mark K. Director | Purchase | +1,734 | +100.00%1,734 | $6.00 | $10,404 | View SEC filing |
1-19 of 19